Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-05-20 00:00:00 ET · period of report 2025-05-20 · accession 0000950170-25-075539 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-20 | 2025-05-20 | AXSM | Coleman Mark | Dir | S - Sale | $107.49 | -3,000 | 54.1K | -5% | -$322.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-20 | S | D | 3,000 | $107.49 | 54,137 | D | — | — | (F2) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $107.34 and $107.65. |